OTLK Outlook Therapeutics, Inc.
$0.64
Outlook Therapeutics, Inc. (OTLK) Earnings News
Earnings press releases, previews and reviews for Outlook Therapeutics, Inc. (OTLK), newest first.
Friday
August 14, 2026
7:15 AM ET
Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™
Wednesday
August 12, 2026
9:45 PM ET
Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants
Wednesday
August 12, 2026
4:01 PM ET
Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
Thursday
August 6, 2026
8:45 AM ET
Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026
Thursday
May 28, 2026
4:00 PM ET
Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Friday
May 15, 2026
4:05 PM ET
Outlook Therapeutics Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update